{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T09:18:52Z","timestamp":1786699132996,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.clineuro.2022.107381","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T22:10:27Z","timestamp":1658355027000},"page":"107381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Clinical and diagnostic spectrum of optic neuritis: A single-center retrospective study of disorders associated with multiple sclerosis, anti-aquaporin-4 and anti-myelin oligodendrocyte glycoprotein antibodies"],"prefix":"10.1016","volume":"221","author":[{"given":"Dana R.","family":"Siegel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Van Harn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meari","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirela","family":"Cerghet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anza B.","family":"Memon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.clineuro.2022.107381_bib1","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","article-title":"The clinical profile of optic neuritis. Experience of the optic neuritis treatment trial","volume":"109","author":"Optic Neuritis Study Group","year":"1991","journal-title":"Arch. Ophthalmol."},{"issue":"6","key":"10.1016\/j.clineuro.2022.107381_bib2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/ICU.0000000000000614","article-title":"Clinical and radiologic approach to \u2018typical\u2019 versus antibody-related optic neuritis","volume":"30","author":"Cantin","year":"2019","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107381_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","article-title":"Optic neuritis","volume":"13","author":"Toosy","year":"2014","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107381_bib4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ijrobp.2013.06.2047","article-title":"Long-term evaluation of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery","volume":"87","author":"Leavitt","year":"2013","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107381_bib5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ohc.2004.05.002","article-title":"Systemic infections of neuro-ophthalmic significance","volume":"17","author":"Lee","year":"2004","journal-title":"Ophthalmol. Clin. North Am."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107381_bib6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1212\/WNL.0b013e318227062a","article-title":"Current and past Epstein-Barr virus infection in risk of initial CNS demyelination","volume":"77","author":"Lucas","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2022.107381_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.msard.2016.11.008","article-title":"Severe structural and functional visual system damage leads to profound loss of vision-related quality of life in patients with neuromyelitis optica spectrum disorders","volume":"11","author":"Schmidt","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107381_bib8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archophthalmol.2010.16","article-title":"Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years","volume":"128","author":"Keltner","year":"2010","journal-title":"Arch. Ophthalmol."},{"issue":"Pt 4","key":"10.1016\/j.clineuro.2022.107381_bib9","article-title":"Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance","volume":"125","author":"Kupersmith","year":"2002","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.clineuro.2022.107381_bib10","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/S0161-6420(96)30429-6","article-title":"Prognostic value of magnetic resonance imaging in monosymptomatic optic neuritis","volume":"103","author":"Dunker","year":"1996","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.clineuro.2022.107381_bib11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/0883073813520500","article-title":"Longitudinally extensive optic neuritis in pediatric patients","volume":"30","author":"Graves","year":"2015","journal-title":"J. Child Neurol."},{"issue":"2","key":"10.1016\/j.clineuro.2022.107381_bib12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clineuro.2022.107381_bib13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107381_bib14","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000012","article-title":"Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton","volume":"1","author":"Dale","year":"2014","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107381_bib15","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000040","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis","volume":"1","author":"Ramanathan","year":"2014","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.clineuro.2022.107381_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7861\/clinmedicine.19-2-169","article-title":"Neuromyelitis optica spectrum disorders","volume":"19","author":"Huda","year":"2019","journal-title":"Clin. Med (Lond. )"},{"key":"10.1016\/j.clineuro.2022.107381_bib17","doi-asserted-by":"crossref","DOI":"10.1177\/1756286418762083","article-title":"Defining distinct features of anti-MOG antibody associated central nervous system demyelination","volume":"11","author":"Weber","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"10","key":"10.1016\/j.clineuro.2022.107381_bib18","first-page":"1385","article-title":"Epidemiologic and clinical characteristics of optic neuritis in Japan","volume":"126","author":"Ishikawa","year":"2019","journal-title":"Observ. StudY Ophthalmol."},{"key":"10.1016\/j.clineuro.2022.107381_bib19","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.3389\/fimmu.2018.02753","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disorders: toward a new spectrum of inflammatory demyelinating CNS disorders?","volume":"9","author":"Di Pauli","year":"2018","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.clineuro.2022.107381_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archopht.1972.01000020137004","article-title":"Optic neuritis and multiple sclerosis. An epidemiologic study","volume":"87","author":"Percy","year":"1972","journal-title":"Arch. Ophthalmol."},{"issue":"2","key":"10.1016\/j.clineuro.2022.107381_bib21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1212\/WNL.45.2.244","article-title":"Optic neuritis: a population-based study in Olmsted County, Minnesota","volume":"45","author":"Rodriguez","year":"1995","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.clineuro.2022.107381_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/1352458517734070","article-title":"A population-based prospective study of optic neuritis","volume":"23","author":"Soelberg","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.clineuro.2022.107381_bib23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/1874364101812010247","article-title":"Clinical characteristics, treatment outcomes and predictive factors in optic neuritis","volume":"12","author":"Hansapinyo","year":"2018","journal-title":"Open Ophthalmol. J."},{"issue":"1\u20132","key":"10.1016\/j.clineuro.2022.107381_bib24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jneuroim.2010.02.007","article-title":"Differential expression of aquaporin-4 isoforms localizes with neuromyelitis optica disease activity","volume":"221","author":"Saini","year":"2010","journal-title":"J. Neuroimmunol."},{"issue":"11","key":"10.1016\/j.clineuro.2022.107381_bib25","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1177\/1352458519864928","article-title":"quaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning","volume":"26","author":"Sotirchos","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.clineuro.2022.107381_bib26","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/1352458515593406","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis","volume":"22","author":"Ramanathan","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.clineuro.2022.107381_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.11604\/pamj.2014.17.54.2462","article-title":"The role of magnetic resonance imaging and visual evoked potential in management of optic neuritis","volume":"17","author":"Al-Eajailat","year":"2014","journal-title":"Pan Afr. Med J."},{"issue":"9","key":"10.1016\/j.clineuro.2022.107381_bib28","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0161-6420(02)01148-X","article-title":"Use of magnetic resonance imaging to differentiate optic neuritis and nonarteritic anterior ischemic optic neuropathy","volume":"109","author":"Rizzo","year":"2002","journal-title":"Ophthalmology"},{"issue":"37","key":"10.1016\/j.clineuro.2022.107381_bib29","first-page":"616","article-title":"The diagnosis and treatment of optic neuritis","volume":"112","author":"Wilhelm","year":"2015","journal-title":"Dtsch Arztebl. Int."},{"key":"10.1016\/j.clineuro.2022.107381_bib30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrneurol.2018.39","article-title":"The current role of MRI in differentiating multiple sclerosis from its imaging mimics","volume":"14","author":"Geraldes","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107381_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","article-title":"Optic neuritis","volume":"13","author":"Toosy","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clineuro.2022.107381_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7861\/clinmedicine.19-2-169","article-title":"Neuromyelitis optica spectrum disorders","volume":"19","author":"Huda","year":"2019","journal-title":"Clin. Med (Lond.)"},{"key":"10.1016\/j.clineuro.2022.107381_bib33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.mcna.2018.10.004","article-title":"Multiple sclerosis and autoimmune neurology of the central nervous system","volume":"103","author":"Galetta","year":"2019","journal-title":"Med. Clin. North Am."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846722002621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846722002621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T20:25:32Z","timestamp":1759955132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846722002621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":33,"alternative-id":["S0303846722002621"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2022.107381","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and diagnostic spectrum of optic neuritis: A single-center retrospective study of disorders associated with multiple sclerosis, anti-aquaporin-4 and anti-myelin oligodendrocyte glycoprotein antibodies","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2022.107381","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107381"}}